Investors

Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.

Financial Reports & Accounts

Date Title Document
22/05/23 Annual Report 2022 Download
14/09/22 Interim Report 2022 Download
24/05/22 Annual Report 2021 Download
17/09/21 Interim Report 2021 Download
21/05/21 Annual Report 2020 Download
14/09/20 Interim Report 2020 Download
30/06/20 Annual Report 2019 Download
30/09/19 Interim Report 2019 Download
24/05/19 Annual Report 2018 Download
27/09/18 Interim Report 2018 Download
01/06/17 Annual Report 2017 Download
13/10/17 Interim Report 2017 Download
10/04/17 Annual Report 2016 Download
22/09/16 Interim Report 2016 Download
13/04/16 Annual Report 2015 Download
14/09/15 Interim Report 2015 Download
15/05/15 Annual Report 2014 Download
24/05/22 Annual Report 2021 Download